Records 1 - 14 (of 14 Records)
|Query Trace: Carcinoma and MMP9[original query]|
| Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population.
Cancer letters 2006 Sep 241 (1): 59-63.
Awakura Yasuo, Ito Noriyuki, Nakamura Eijiro, Takahashi Takeshi, Kotani Hirokazu, Mikami Yoshiki, Manabe Toshiyuki, Kamoto Toshiyuki, Habuchi Tomonori, Ogawa Osa
| Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
Human mutation 2007 Nov 28 (11): 1091-7.
Zhou Gangqiao, Zhai Yun, Cui Ying, Qiu Wei, Yang Hao, Zhang Xiumei, Dong Xiaojia, He Ying, Yao Kaitai, Zhang Hongxing, Peng Yong, Yuan Xiaoyan, Zhi Lianteng, Zhang Xiaoai, He Fuc
| Missense polymorphisms in matrix metalloproteinase genes and skin cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Dec 17 (12): 3551-7.
Nan Hongmei, Niu Tianhua, Hunter David J, Han Jia
| MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation.
Clinical genetics 2008 Mar 73 (3): 273-8.
Wu L M, Zhang F, Xie H Y, Xu X, Chen Q X, Yin S Y, Liu X C, Zhou L, Xu X B, Sun Y L, Zheng S
| Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis.
Journal of cancer research and clinical oncology 2013 Sep 139 (9): 1433-47.
Li Xiaoying, Qu Lianxi, Zhong Yu, Zhao Yingjie, Chen Hongyan, Daru
| A miR-151 binding site polymorphism in the 3'-untranslated region of the cyclin E1 gene associated with nasopharyngeal carcinoma.
Biochemical and biophysical research communications 2013 Mar 432 (4): 660-5.
Liu Ying, Cai Hongbing, Liu Jie, Fan Haoning, Wang Zhiyuan, Wang Qirui, Shao Meng, Sun Xuegang, Diao Jianxin, Liu Yuanliang, Shi Yusheng, Fan Q
| Matrix metalloproteinase 1, 3, and 9 polymorphisms and esophageal squamous cell carcinoma risk.
Medical science monitor : international medical journal of experimental and clinical research 2014 20 2269-74.
Guan Xuan, Wang Xiang, Luo Hao, Wu Jing, Zhang Xiao, Wu J
| MMP1, 2, 3, 7, and 9 gene polymorphisms and urinary cancer risk: a meta-analysis.
Genetic testing and molecular biomarkers 2015 Aug .
Tao Liu, Li Zuo, Lin Li, Lei Yin, Hongyuan Yu, Hongwei Jing, Yang Liu, Chuize Ko
| Matrix metalloproteinase variants associated with risk and clinical outcome of esophageal cancer.
Genetics and molecular research : GMR 2015 14 (2): 4616-24.
Zhang L, Xi R-X, Zhang X
| Association of Smoking and XPG, CYP1A1, OGG1, ERCC5, ERCC1, MMP2, and MMP9 Gene Polymorphisms with the early detection and occurrence of Laryngeal Squamous Carcinoma.
Journal of Cancer 2018 9 (6): 968-977.
Zhu Yi, Guo Luo, Wang ShengZi, Yu Qun, Lu JianXio
| MMP9 and IGFBP1 Regulate Tumor Immune and Drive Tumor Progression in Clear Cell Renal Cell Carcinoma.
Journal of Cancer 2021 3 12 (8): 2243-2257.
Xu Tianbo, Gao Su, Liu Jingchong, Huang Yu, Chen Ke, Zhang Xiaopi
| Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development.
Frontiers in immunology 2022 8 13 926236.
Pipitone Rosaria Maria, Calvaruso Vincenza, Di Marco Lorenza, Di Salvo Francesca, Gaggianesi Miriam, Lupo Giulia, Zito Rossella, La Mantia Claudia, Ramazzotti Matteo, Petta Salvatore, Di Marco Vito, Craxì Antonio, Grimaudo Stefan
| Matrix metalloproteinase gene mutations and bioinformatics of telocytes in hepatocellular carcinoma.
Cell biology international 2022 10 47 (1): 110-122.
Luan Chaoguang, Xu Yi
| Gene polymorphisms of cyclin-dependent kinase inhibitor and matrix metalloproteinase-9 in Sudanese patients with esophageal squamous cell carcinoma.
Molecular genetics & genomic medicine 2022 Oct e2074.
Eltayeb Majdolin Mohammed, Ali Mohamed M, Omar Saeed M, Mohamed Nouh Saad, Adam Ishag, Hamdan Hamdan
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 28, 2023
- Content source: